Lartruvo

List of products in the National Drug Code with proprietary name lartruvo. This medication is used to treat a certain type of cancer (soft tissue sarcoma). Talk to your doctor about the benefits and risks of treatment with olaratumab. In Europe, this medication is being withdrawn from the market due to lack of effectiveness in a clinical study. This medication belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0002-7190Lartruvo Eli Lilly And Company
0002-8926Lartruvo Eli Lilly And Company